Protocol Design Featured Articles

  1. What Future Laboratory Manuals Should Look Like 12/20/2024

    In the final article of this series on lab manuals, FlexPoint Bio Founder and CEO Elena Sinclair imagines what the perfect lab manual might look like — and how to make it a reality.

  2. How Laboratory Manuals Fail Sites And Sponsors 12/19/2024

    In part one of this series, FlexPoint Bio Founder and CEO Elena Sinclair describes the hazards of poorly designed (and followed) clinical trial lab manuals.

  3. Lab Manual Gaps: Sabotaging Data One Sample At A Time 12/19/2024

    In part two of this series on lab manuals, FlexPoint Bio Founder and CEO Elena Sinclair discusses the criticality of sample and process quality.

  4. BeiGene Details Its Approach To Expanding Oncology Trials Into Brazil 12/17/2024

    In this second article, BeiGene's Lígia Campos details its journey to setting roots in Brazil, sharing its beginnings there and highlighting its approach to study start-up and patient recruitment and enrollment.

  5. BeiGene Explains The Landscape Of Oncology Trials In Brazil 12/16/2024

    In part one of this two-part series, BeiGene's Brazil and LATAM clinical operations head Lígia Campos details Brazil's cancer treatment landscape and the benefits of expanding oncology trials there.

  6. I AM INCLUDED: 8 Best Practices For Sites To Drive More Inclusive Clinical Trials 12/13/2024

    Discover the I AM INCLUDED framework, along with the actionable practices it provides to help all types of clinical trial sites extend the reach of their research.

  7. What's Needed To Transform Clinical Trials In Early-Stage Prostate Cancer 12/9/2024

    President and CEO of Candel Therapeutics Paul Peter Tak, MD, Ph.D., FMedSci calls for changes in early-stage prostate cancer clinical trials, from biomarkers to endpoints to technology.

  8. How Did Clinical Researchers Actually Use AI In 2024? 12/5/2024

    Looking ahead to 2025, Clinical Leader seeks to understand how clinical research professionals are incorporating AI into their work. So we asked them, “Simply put: Are you using any iteration of AI in your role within clinical research? If so, how and why?”

  9. Top 4 Trends For Neuropsychiatric Disease Research In 2025 12/3/2024

    Arrivo BioVentures' Kelly Abernathy and Joel Raskin, MD identify what they think will be the top four trends in neuropsychiatric disease research in the new year.

  10. 2024: Familiar Problems & Encouraging Progress 11/27/2024

    For part 1 of my 2024 recap, I asked various industry experts what stood out to them this year regarding the clinical trials industry. They mentioned significant challenges related to site capacity, enrollment, workforce changes, and trial complexity, but they also seemed encouraged with some of the efforts and emerging solutions that will address these issues.